Go Pro
→ My top 3 AI picks for the next decade (From The Oxford Club) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GMVDF
G Medical Innovations
$0.00
$0.00
▼
$0.03
$26K28.6611,627 shsN/A
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
$0.00
$0.00
$0.00
▼
$0.20
$10K5.761,464 shsN/A
SDCCQ
SmileDirectClub
$0.00
$0.00
▼
$0.01
$40K1.3566,098 shs45,150 shs
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
$0.01
$0.00
$0.00
▼
$2.65
$29K0.03180,650 shs619 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GMVDF
G Medical Innovations
0.00%0.00%0.00%0.00%0.00%
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
0.00%0.00%-50.00%-71.43%-33.33%
SDCCQ
SmileDirectClub
0.00%0.00%0.00%0.00%0.00%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
0.00%0.00%0.00%-96.18%-99.77%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GMVDF
G Medical Innovations
$0.00
$0.00
▼
$0.03
$26K28.6611,627 shsN/A
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
$0.00
$0.00
$0.00
▼
$0.20
$10K5.761,464 shsN/A
SDCCQ
SmileDirectClub
$0.00
$0.00
▼
$0.01
$40K1.3566,098 shs45,150 shs
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
$0.01
$0.00
$0.00
▼
$2.65
$29K0.03180,650 shs619 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GMVDF
G Medical Innovations
0.00%0.00%0.00%0.00%0.00%
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
0.00%0.00%-50.00%-71.43%-33.33%
SDCCQ
SmileDirectClub
0.00%0.00%0.00%0.00%0.00%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
0.00%0.00%0.00%-96.18%-99.77%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GMVDF
G Medical Innovations
0.00
N/AN/AN/A
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
0.00
N/AN/AN/A
SDCCQ
SmileDirectClub
0.00
N/AN/AN/A
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GMVDF
G Medical Innovations
$4.42M0.00N/AN/AN/ANaN
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
$1.98M0.00N/AN/AN/A∞
SDCCQ
SmileDirectClub
$470.74M0.00N/AN/AN/ANaN
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
$30.98M0.00N/AN/A$1.19 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GMVDF
G Medical Innovations
-$24.63MN/AN/AN/AN/AN/AN/AN/AN/A
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
-$29.31M-$0.96N/AN/AN/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
-$86.40M-$0.13N/AN/AN/AN/AN/AN/AN/A
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
-$10.09M-$1.41N/AN/AN/A-35.64%-476.73%-33.49%11/17/2026 (Estimated)
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GMVDF
G Medical Innovations
N/AN/AN/AN/AN/A
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
N/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/AN/AN/A
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GMVDF
G Medical Innovations
N/AN/AN/A
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
N/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/A
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
10.22
0.95
0.75

Institutional Ownership

CompanyInstitutional Ownership
GMVDF
G Medical Innovations
5.96%
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
0.02%
SDCCQ
SmileDirectClub
0.07%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
32.43%

Insider Ownership

CompanyInsider Ownership
GMVDF
G Medical Innovations
37.10%
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
10.80%
SDCCQ
SmileDirectClub
64.70%
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
40.92%
CompanyEmployeesShares OutstandingFree FloatOptionable
GMVDF
G Medical Innovations
84259.92 million163.49 millionNot Optionable
Pressure BioSciences Inc. stock logo
PBIO
Pressure BioSciences
1642.97 million38.33 millionNot Optionable
SDCCQ
SmileDirectClub
2,700402.23 million142.12 millionNo Data
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
1145.89 million3.48 millionNot Optionable

Recent News About These Companies

STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer
July 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334372/23161/en/strata-skin-sciences-appoints-medical-device-commercial-leader-erica-jordan-as-chief-executive-officer.html
New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
May 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/18/3296628/23161/en/new-peer-reviewed-publication-confirms-unprecedented-response-rates-for-strata-s-excimer-laser-combined-with-jak-inhibitors-in-pediatric-vitiligo.html
STRATA Skin Sciences Confirms Nasdaq Delisting
February 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/19/3241523/23161/en/strata-skin-sciences-confirms-nasdaq-delisting.html
SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy
February 18, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2871290/sskn-stock-falls-despite-meta-analysis-backs-excimer-laser-s-efficacy?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-2871290
STRATA cites study supporting 308 nm laser for psoriasis
February 18, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/strata-cites-study-supporting-308-nm-laser-for-psoriasis/ar-AA1WzU47
Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser
February 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/18/3240190/23161/en/johns-hopkins-dermatology-expands-advanced-care-for-inflammatory-and-autoimmune-skin-conditions-with-addition-of-xtrac-excimer-laser.html
STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis
February 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/17/3239251/23161/en/strata-skin-sciences-highlights-meta-analysis-confirming-clinical-efficacy-of-308-nm-excimer-laser-for-plaque-psoriasis.html
STRATA Skin Sciences stock plunges after Nasdaq delisting notice
February 12, 2026  |  in.investing.comhttps://in.investing.com/news/stock-market-news/strata-skin-sciences-stock-plunges-after-nasdaq-delisting-notice-93CH-5237449
Strata Skin Sciences to Delist and Go Dark
February 11, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/strata-skin-sciences-to-delist-and-go-dark?utm_source=marketbeat.com&utm_medium=referral
Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences
February 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/11/3236209/0/en/laseroptek-america-files-counterclaims-alleging-anticompetitive-and-unfair-business-practices-in-ongoing-litigation-with-strata-skin-sciences.html
Strata Skin Sciences showcases XTRAC, TheraclearX at TeraCILAD 2025
December 10, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/strata-skin-sciences-showcases-xtrac-theraclearx-at-teracilad-2025/ar-AA1S16BC
STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico
December 9, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/09/3202329/23161/en/strata-skin-sciences-showcases-xtrac-and-theraclearx-at-teracilad-2025-reports-early-adoption-momentum-in-mexico.html
Strata Skin Sciences Inc (SSKN) Q3 2025 Earnings Call Highlights: Navigating Challenges and ...
November 16, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/strata-skin-sciences-inc-sskn-030059482.html
STRATA Skin Sciences Reports Q3 2025 Financial Results
November 14, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/strata-skin-sciences-reports-q3-2025-financial-results/ar-AA1Qqh6N
Strata Skin Sciences Reports Q3 2025 Revenue Decline
November 13, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/strata-skin-sciences-reports-q3-2025-revenue-decline/ar-AA1QpaZC
STRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call Transcript
November 13, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4843584-strata-skin-sciences-inc-sskn-q3-2025-earnings-call-transcript
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 13, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/strata-skin-sciences-reports-third-quarter-2025-financial-results-and-provides-a-corporate-update-1035557489
STRATA Skin Sciences to Report Q3 Results and Host Investor Call November 13
November 13, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/strata-skin-sciences-to-report-q3-results-and-host-investor-call-november-13/ar-AA1QkemV
A Peek at Strata Skin Sciences's Future Earnings
November 13, 2025  |  benzinga.comhttps://www.benzinga.com/insights/earnings/25/11/48808544/a-peek-at-strata-skin-sciencess-future-earnings
Strata Skin Sciences announces CMS recognition of expanded CPT codes
November 6, 2025  |  msn.comhttps://www.msn.com/en-us/fashion-and-style/skin-care/strata-skin-sciences-announces-cms-recognition-of-expanded-cpt-codes/ar-AA1PWcX9

New MarketBeat Followers Over Time

G Medical Innovations NASDAQ:GMVDF

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.

Pressure BioSciences stock logo

Pressure BioSciences OTCMKTS:PBIO

$0.0002 0.00 (0.00%)
As of 09/21/2026

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.

SmileDirectClub NASDAQ:SDCCQ

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee. On January 26, 2024, the voluntary petition of SmileDirectClub, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 29, 2023..

Strata Skin Sciences stock logo

Strata Skin Sciences NASDAQ:SSKN

$0.0050 0.00 (0.00%)
As of 09/24/2026 03:05 PM Eastern

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas